Financials data is unavailable for this security.
View more
Year on year Pharma Foods International Co Ltd had revenues fall -9.37% from 68.57bn to 62.15bn, though the company grew net income 4.09% from 3.08bn to 3.21bn.
| Gross margin | 78.45% |
|---|---|
| Net profit margin | 5.16% |
| Operating margin | 7.87% |
| Return on assets | 8.81% |
|---|---|
| Return on equity | 30.21% |
| Return on investment | 25.38% |
More ▼
Cash flow in JPYView more
In 2024, Pharma Foods International Co Ltd did not generate a significant amount of cash. However, the company earned 5.49bn from its operations for a Cash Flow Margin of 8.83%. In addition the company used 1.39bn on investing activities and also paid 4.84bn in financing cash flows.
| Cash flow per share | 144.62 |
|---|---|
| Price/Cash flow per share | 6.23 |
| Book value per share | 412.69 |
|---|---|
| Tangible book value per share | 406.38 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.18 |
|---|---|
| Quick ratio | 0.8875 |
| Total debt/total equity | 1.46 |
|---|---|
| Total debt/total capital | 0.5932 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 13.64% and 5.62%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Biotechnology & Drugs industry pay a dividend. Additionally, five year annualized earnings per share growth ranks highest in its industry.
| Div yield(5 year avg) | 1.30% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 8.74% |
| EPS growth(5 years) | 45.61 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 5.87 |
More ▼
